Key statistics
As of last trade Cassava Sciences Inc (PX91:FRA) traded at 25.59, -32.66% below its 52-week high of 38.00, set on Aug 06, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 24.54 |
---|---|
High | 25.59 |
Low | 24.54 |
Bid | 25.07 |
Offer | 25.59 |
Previous close | 24.70 |
Average volume | 985.50 |
---|---|
Shares outstanding | 47.98m |
Free float | 42.29m |
P/E (TTM) | -- |
Market cap | 1.30bn USD |
EPS (TTM) | -0.4054 USD |
Data delayed at least 15 minutes, as of Oct 07 2024 11:10 BST.
More ▼
Announcements
- Cassava Sciences Resolves SEC Investigation
- Cassava Sciences Announces Completion of an Interim Safety Review of Oral Simufilam On-going Phase 3 Trials
- Cassava Sciences Names Rick Barry as Chief Executive Officer
- Cassava Sciences to Present at the H.C. Wainwright Global Investment Conference
- Cassava Sciences Reports Q2 2024 Financial Results and Operational Updates
- Cassava Sciences Mourns the Death of Board Member Sanford “Sandy” Robertson
- Cassava Sciences to Hold Conference Call to Discuss Recent Developments and Provide a Company Update on Thursday, August 8, 2024 at 8:30 am ET
- Cassava Sciences Announces Expansion of Open-Label Extension Trials
- Cassava Sciences Announces Changes in Executive Leadership, Enhanced Corporate Governance and Other Initiatives
- Cassava Sciences Issues Statement on Former Science Advisor
More ▼